The efficacy of peginterferon Beta-1a in early and later-stage patients with multiple sclerosis: A 1-year subgroup analysis based on disease duration from the advance study

Authors
Category Primary study
JournalNeurology
Year 2015
This article has no abstract
Epistemonikos ID: 203ba5fbc62210a264adc499868d1cd5dccd771b
First added on: Feb 07, 2025